Garcia-Mazcorro J F, Rodriguez-Herrera M V, Marroquin-Cardona A G, Kawas J R
Research and Development, MNA de México, San Nicolás de los Garza, México.
Faculty of Veterinary Medicine, Universidad Autónoma de Nuevo León, General Escobedo, México.
Lett Appl Microbiol. 2019 May;68(5):472-478. doi: 10.1111/lam.13141. Epub 2019 Mar 19.
The health enhancer yeast Saccharomyces cerevisiae (SC) is widely used in diets for different animals. Two main types of SC-based products are commercially available, one containing live yeasts and one containing SC fermentation by-products, which are supposedly not dependent on live yeasts for their physiological effects in vivo. Culture-based techniques were applied to study yeasts in two types of commercial products: a product containing live SC (LSC) and a SC fermentation product (SCFP). Three temperatures (25, 30 and 39°C) and two pH levels (4 and 7) were tested. The product with LSC contained an average of 1·21 × 10 colony-forming units (CFUs) of yeasts per g contents (min: 1 × 10 , max: 3 × 10 ). In contrast, the SCFP contained an average of 4·67 × 10 (min: 3 × 10 , max: 1·9 × 10 ) CFUs per g contents (c. 1 million times less than the concentration of yeasts in the product with LSC). Both temperature and pH level affected the number of CFUs but this effect differed between the two products. Biochemical tests identified the two yeasts as SC, which differed in their ability to ferment maltose (negative in the SCFP). This report encourages more research on commercial microbial strains for animal nutrition that can lead to a better understanding of their mode of action in vivo. SIGNIFICANCE AND IMPACT OF THE STUDY: Probiotics (or direct fed microbials) are increasingly popular in Animal Nutrition. Different products containing live micro-organisms or microbial-derived products are commercially available to enhance health and boost commercial traits. The characteristics of these products dictate their physiological effects and determine their potential to increase profitability from livestock. For the first time, this report presents data about the numbers and phenotype of the health enhancer Saccharomyces cerevisiae in two widely available commercial products in Animal Nutrition. These findings may be useful for scientists and producers around the globe and have the potential to open up novel venues for research.
健康增强型酵母酿酒酵母(SC)被广泛应用于不同动物的日粮中。市面上有两种主要的基于SC的产品,一种含有活酵母,另一种含有SC发酵副产物,据推测其体内生理效应不依赖于活酵母。采用基于培养的技术研究了两种商业产品中的酵母:一种含有活SC的产品(LSC)和一种SC发酵产品(SCFP)。测试了三个温度(25、30和39°C)和两个pH水平(4和7)。LSC产品每克内容物平均含有1.21×10个酵母菌落形成单位(CFU)(最小值:1×10,最大值:3×10)。相比之下,SCFP产品每克内容物平均含有4.67×10个CFU(最小值:3×10,最大值:1.9×10)(比LSC产品中的酵母浓度少约100万倍)。温度和pH水平均影响CFU数量,但两种产品的这种影响有所不同。生化测试确定这两种酵母为SC,它们在发酵麦芽糖的能力上有所不同(SCFP中为阴性)。本报告鼓励对用于动物营养的商业微生物菌株进行更多研究,以更好地了解它们在体内的作用方式。研究的意义和影响:益生菌(或直接投喂微生物)在动物营养中越来越受欢迎。市面上有不同的含有活微生物或微生物衍生产品的产品,用于增强健康和提升商业性状。这些产品的特性决定了它们的生理效应,并决定了它们提高牲畜盈利能力的潜力。本报告首次提供了关于动物营养中两种广泛使用的商业产品中健康增强型酿酒酵母数量和表型的数据。这些发现可能对全球的科学家和生产者有用,并有可能开辟新的研究途径。